Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J AITCHISON

Showing results (71-80 of 180) with videos related to

Pageof 18
Sort By:
Paediatric Drugs|March 23, 2013
Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysisNoor B Almandil, Ying Liu, Macey L Murray, et al.
Schizophrenia Research|June 1, 2014
Potential role of the combination of galantamine and memantine to improve cognition in schizophreniaMaju Mathew Koola, Robert W Buchanan, Anilkumar Pillai, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 16, 2015
Role of a Combination of Seven Micronutrients in the Management of Glioblastoma MultiformeH K Rooprai, K Ashkan, L Brazil, et al.
Journal of Psychopharmacology (Oxford, England)|March 6, 2014
Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?Maju M Koola, Evangelia M Tsapakis, Padraig Wright, et al.
Journal of Cell Science|June 1, 1991
Mitogens induce calcium transients in both dividing and terminally differentiating keratinocytesF M Watt, D L Hudson, A G Lamb, et al.
Pharmacogenetics and Genomics|October 22, 2011
Antidepressants and the resilience to early-life stress in inbred mouse strainsElke Binder, Karim Malki, Jose L Paya-Cano, et al.
Pharmacogenetics|March 30, 2000
Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's diseaseA J Makoff, J M Graham, M J Arranz, et al.
Schizophrenia Research|August 26, 1998
Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophreniaT Li, M Arranz, K J Aitchison, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 11, 2020
Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?Philip G Tibbo, Kyle A McKee, Jeffrey H Meyer, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 29, 2024
Optimizing the Prediction of Depression Remission: A Longitudinal Machine Learning ApproachEwan Carr, Marcella Rietschel, Ole Mors, et al.
Pageof 18

Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Paediatric Drugs|March 23, 2013
Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysisNoor B Almandil, Ying Liu, Macey L Murray, et al.
Schizophrenia Research|June 1, 2014
Potential role of the combination of galantamine and memantine to improve cognition in schizophreniaMaju Mathew Koola, Robert W Buchanan, Anilkumar Pillai, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 16, 2015
Role of a Combination of Seven Micronutrients in the Management of Glioblastoma MultiformeH K Rooprai, K Ashkan, L Brazil, et al.
Journal of Psychopharmacology (Oxford, England)|March 6, 2014
Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?Maju M Koola, Evangelia M Tsapakis, Padraig Wright, et al.
Journal of Cell Science|June 1, 1991
Mitogens induce calcium transients in both dividing and terminally differentiating keratinocytesF M Watt, D L Hudson, A G Lamb, et al.
Pharmacogenetics and Genomics|October 22, 2011
Antidepressants and the resilience to early-life stress in inbred mouse strainsElke Binder, Karim Malki, Jose L Paya-Cano, et al.
Pharmacogenetics|March 30, 2000
Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's diseaseA J Makoff, J M Graham, M J Arranz, et al.
Schizophrenia Research|August 26, 1998
Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophreniaT Li, M Arranz, K J Aitchison, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 11, 2020
Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?Philip G Tibbo, Kyle A McKee, Jeffrey H Meyer, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 29, 2024
Optimizing the Prediction of Depression Remission: A Longitudinal Machine Learning ApproachEwan Carr, Marcella Rietschel, Ole Mors, et al.
Pageof 18